KyungDong Pharm Co., Ltd. launches Alzheimer's dementia treatment drug “Donepem Tablet” on May 1, 2020.
“Donepem tablets,” which contain donepezil as the main ingredient, play a role in improving cognitive function by increasing the concentration of acetylcholine in dementia patients.
It is released in two strengths, 5mg and 10mg, and the dose can be increased depending on symptoms, and can be administered and fed from the early to advanced stages of Alzheimer's type dementia.
In addition, when used in combination with memantine preparations, nursing care benefits are recognized if symptoms of moderate or severe dementia in the form of Alzheimer's disease (including Alzheimer's disease accompanied by cerebrovascular disease) meet the reimbursement standards for each drug.
We hope that the launch of KyungDong Pharm Co., Ltd.'s new product “Donepem Tablet” will help treat dementia patients, which are rapidly increasing due to aging.
▣ Product Information ▣
|
Product Name |
Donepem tablet 5mg |
Donepem tablet 10mg |
|
Ingredient content |
5mg as donepezil hydrochloride |
10mg as donepezil hydrochloride |
|
Indications |
Treatment of Alzheimer's type dementia symptoms | |
|
Dosage and usage |
Adults: 5 mg once daily before bedtime. Administer at a dose of 5 mg for 4 to 6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. -Elderly women who are underweight should not exceed 5mg per day. | |
|
Reimbursement Prices |
2,060 won |
2,460 won |
|
Reimbursement Code |
648104420 |
648104430 |
|
Packaging unit |
30 tablets/bottle |
30 tablets/bottle |
※ Please refer to the product manual for other details such as precautions for use.